(Q34174861)

English

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Stuart W McCombie

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jayaram R Tagat

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Susan F Vice

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sue-Ing Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ruo Steensma

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Anandan Palani

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Bernard R Neustadt

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Bahige M Baroudy

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Julie M Strizki

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michael Endres

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kathleen Cox

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Niya Dan

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chuan-Chu Chou

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

567-571

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailabl

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Axially chiral N-benzyl-N,7-dimethyl-5-phenyl-1, 7-naphthyridine-6-carboxamide derivatives as tachykinin NK1 receptor antagonists: determination of the absolute stereochemical requirements.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Atropisomeric Amides as Chiral Ligands: Using (−)-Sparteine-Directed Enantioselective Silylation to Control the Conformation of a Stereogenic Axis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis of enantioenriched axially chiral anilides from atropisomerically enriched tartarate ortho-anilides.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reaction of N-Aminopyridinium Derivatives. V. Syntheses of 1-(N-Methylacetamido) alkylpyridinium Salts and Their Reaction with Cyanide Ion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Benzo- and pyrido-1,4-oxazepin-5-ones and -thiones: synthesis and structure-activity relationships of a new series of H1 antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

SCH 57790: a novel M2 receptor selective antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel procedure for rapid pharmacokinetic screening of discovery compounds in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Formamid-Reaktionen, XI. Darstellung, Eigenschaften und Umsetzungen des Pyrimidins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of 4-[(Z)-(4-bromophenyl)- (ethoxyimino)methyl]-1'-[(2,4-dimethyl-3- pyridinyl)carbonyl]-4'-methyl-1,4'- bipiperidine N-oxide (SCH 351125): an orally bioavailable human CCR5 antagonist for the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900918-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(02)00918-6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34174861&oldid=2143354551"